OCX logo

OncoCyte (OCX) Selling, General & Administrative Expenses

Annual SGA

$13.54 M
-$8.00 M-37.14%

December 31, 2023

Summary

Performance

1-Year Change

-37.14%

3-Year Change

-41.86%

5-Year Change

+55.8%

15-Year Change

+15.94%

OCX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.08%
OCX annual SGA is higher than 31.08% of companies in Healthcare sector

High & Low

All-time High

$23.28 M
OCX annual SGA is currently -41.86% below its historical high of $23.28 million

3-Year Low

$13.54 M
OCX annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OCX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 11, 2025
OCX next annual earnings announcement is scheduled for Apr 11, 2025

OtherOCXexpensesmetrics:

Annual Total Expenses

$23.92 M
OCX annual total expenses is $23.92 million

Annual Operating Expenses

$22.83 M
OCX annual total operating expenses is $22.83 million

Annual Cost Of Goods Sold

$1.09 M
OCX annual cost of goods sold is $1.09 million

Annual Interest Expense

$52.00 K
OCX annual interest expense is $52.00 thousand

Quarterly SGA

$3.61 M
+$348.00 K+10.67%

September 30, 2024

Summary

Performance

3-Month Change

+10.67%

1-Year Change

+13.35%

3-Year Change

-33.77%

5-Year Change

-33.77%

OCX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.29%
OCX quarterly SGA is higher than 30.29% of companies in Healthcare sector

High & Low

All-time High

$8.43 M
OCX quarterly SGA is currently -57.18% below its historical high of $8.43 million

3-Year Low

-$3.21 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXexpensesmetrics:

Quarterly Total Expenses

$6.49 M
OCX quarterly total expenses is $6.49 million

Quarterly Operating Expenses

$6.42 M
OCX quarterly total operating expenses is $6.42 million

Quarterly Cost Of Goods Sold

$65.00 K
OCX quarterly cost of goods sold is $65.00 thousand

Quarterly Interest Expense

$31.00 K
OCX quarterly interest expense is $31.00 thousand

TTM SGA

-$1.21 B
-$44.56 M-3.83%

September 30, 2024

Summary

Performance

3-Month Change

-9890.69%

1-Year Change

-7770.24%

3-Year Change

-7394.6%

5-Year Change

-7394.6%

OCX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.93%
OCX TTM SGA is higher than 39.93% of companies in Healthcare sector

High & Low

All-time High

-$15.40 M

3-Year Low

-$1.21 B
OCX TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXexpensesmetrics:

Annual Total Expenses

$23.92 M
OCX annual total expenses is $23.92 million

Annual Operating Expenses

$22.83 M
OCX annual total operating expenses is $22.83 million

TTM Cost Of Goods Sold

$824.00 K
OCX TTM cost of goods sold is $824.00 thousand

TTM Interest Expense

$67.00 K
OCX TTM interest expense is $67.00 thousand

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$13.54 M
OCX annual SGA is $13.54 million

Annual Operating Expenses

$22.83 M
OCX annual total operating expenses is $22.83 million

Annual Cost Of Goods Sold

$1.09 M
OCX annual cost of goods sold is $1.09 million

OCX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-37.1%+13.3%-7770.2%
3 y3 years-41.9%-33.8%-7394.6%
5 y5 years+55.8%-33.8%-7394.6%

OCX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.1%at low-39.0%+212.5%-99.8%at low
5 y5-year-41.9%at low-57.2%+212.5%-260.7%at low
alltimeall time-41.9%+2352.2%-57.2%+212.5%-7754.0%at low

OncoCyte Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.61 M(+10.7%)
$12.78 M(+3.4%)
Jun 2024
-
$3.26 M(-7.4%)
$12.35 M(-4.6%)
Mar 2024
-
$3.52 M(+47.2%)
$12.95 M(-4.3%)
Dec 2023
$13.54 M(-37.1%)
$2.39 M(-24.9%)
$13.54 M(-14.2%)
Sep 2023
-
$3.18 M(-17.4%)
$15.77 M(-13.0%)
Jun 2023
-
$3.85 M(-6.1%)
$18.13 M(-8.1%)
Mar 2023
-
$4.11 M(-11.2%)
$19.73 M(-8.4%)
Dec 2022
$21.53 M(+5.6%)
$4.62 M(-16.7%)
$21.53 M(+57.1%)
Sep 2022
-
$5.55 M(+1.9%)
$13.70 M(-17.4%)
Jun 2022
-
$5.45 M(-7.9%)
$16.58 M(-14.6%)
Mar 2022
-
$5.91 M(-284.4%)
$19.42 M(-5.4%)
Dec 2021
$20.39 M(-12.4%)
-$3.21 M(-138.1%)
$20.52 M(-29.3%)
Sep 2021
-
$8.43 M(+1.7%)
$29.01 M(+6.9%)
Jun 2021
-
$8.28 M(+18.0%)
$27.15 M(+12.3%)
Mar 2021
-
$7.02 M(+32.8%)
$24.19 M(+3.9%)
Dec 2020
$23.28 M(+50.7%)
$5.28 M(-19.5%)
$23.28 M(+0.3%)
Sep 2020
-
$6.56 M(+23.3%)
$23.20 M(+14.5%)
Jun 2020
-
$5.32 M(-13.0%)
$20.27 M(+7.2%)
Mar 2020
-
$6.12 M(+17.5%)
$18.91 M(+22.4%)
Dec 2019
$15.45 M
$5.21 M(+43.3%)
$15.45 M(+18.1%)
DateAnnualQuarterlyTTM
Sep 2019
-
$3.63 M(-8.1%)
$13.08 M(+19.5%)
Jun 2019
-
$3.95 M(+49.0%)
$10.95 M(+23.0%)
Mar 2019
-
$2.65 M(-6.6%)
$8.90 M(+2.4%)
Dec 2018
$8.69 M(-25.6%)
$2.84 M(+90.0%)
$8.69 M(+5.6%)
Sep 2018
-
$1.50 M(-21.4%)
$8.23 M(-29.9%)
Jun 2018
-
$1.90 M(-22.1%)
$11.73 M(+2.7%)
Mar 2018
-
$2.44 M(+2.5%)
$11.42 M(-2.2%)
Dec 2017
$11.68 M(+113.7%)
$2.38 M(-52.3%)
$11.67 M(+6.6%)
Sep 2017
-
$5.00 M(+214.0%)
$10.95 M(+52.7%)
Jun 2017
-
$1.59 M(-41.0%)
$7.17 M(+3.7%)
Mar 2017
-
$2.70 M(+62.2%)
$6.92 M(+26.6%)
Dec 2016
$5.46 M(+30.4%)
$1.66 M(+36.4%)
$5.46 M(-7.6%)
Sep 2016
-
$1.22 M(-8.8%)
$5.91 M(-1.5%)
Jun 2016
-
$1.34 M(+7.6%)
$6.00 M(+15.8%)
Mar 2016
-
$1.24 M(-41.1%)
$5.18 M(+23.7%)
Dec 2015
$4.19 M(+314.5%)
$2.11 M(+60.8%)
$4.19 M(+70.8%)
Sep 2015
-
$1.31 M(+152.8%)
$2.45 M(+114.9%)
Jun 2015
-
$519.00 K(+107.6%)
$1.14 M(+83.3%)
Mar 2015
-
$250.00 K(-33.0%)
$623.00 K(+67.0%)
Dec 2014
$1.01 M(+83.2%)
$373.00 K
$373.00 K
Dec 2013
$552.00 K
-
-

FAQ

  • What is OncoCyte annual SGA?
  • What is the all time high annual SGA for OncoCyte?
  • What is OncoCyte annual SGA year-on-year change?
  • What is OncoCyte quarterly SGA?
  • What is the all time high quarterly SGA for OncoCyte?
  • What is OncoCyte quarterly SGA year-on-year change?
  • What is OncoCyte TTM SGA?
  • What is the all time high TTM SGA for OncoCyte?
  • What is OncoCyte TTM SGA year-on-year change?

What is OncoCyte annual SGA?

The current annual SGA of OCX is $13.54 M

What is the all time high annual SGA for OncoCyte?

OncoCyte all-time high annual SGA is $23.28 M

What is OncoCyte annual SGA year-on-year change?

Over the past year, OCX annual SGA has changed by -$8.00 M (-37.14%)

What is OncoCyte quarterly SGA?

The current quarterly SGA of OCX is $3.61 M

What is the all time high quarterly SGA for OncoCyte?

OncoCyte all-time high quarterly SGA is $8.43 M

What is OncoCyte quarterly SGA year-on-year change?

Over the past year, OCX quarterly SGA has changed by +$425.00 K (+13.35%)

What is OncoCyte TTM SGA?

The current TTM SGA of OCX is -$1.21 B

What is the all time high TTM SGA for OncoCyte?

OncoCyte all-time high TTM SGA is -$15.40 M

What is OncoCyte TTM SGA year-on-year change?

Over the past year, OCX TTM SGA has changed by -$1.23 B (-7770.24%)